SANCILIO PHARMACEUTICALS COMPANY, INC. — Form D

SANCILIO PHARMACEUTICALS COMPANY, INC. of RIVIERA BEACH, FL, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-22. The offering totals $5.5M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2018-01-22
Form: D
Accession: 0001641908-18-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $5.5M
Amount sold: $5.0M
Remaining: $500K
Minimum investment: $193K
Investors: 7
Date of first sale: 2018-01-09
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-303770

Issuer

Name: SANCILIO PHARMACEUTICALS COMPANY, INC.
CIK: 0001641908
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2015
Address: 2129 N. CONGRESS AVENUE, RIVIERA BEACH, FL, 33404
Phone: 561-847-2302

Officers, directors & promoters (13)

Name	Role	Location
John Celentano	Director	Riviera Beach, FL
Jim Gale	Director	Riviera Beach, FL
Geoffrey Glass	Director	Riviera Beach, FL
Patrick Gray	Director	Seattle, WA
Oscar Groet	Director	Riviera Beach, FL
Dennis Langer	Director	Naples, FL
FREDERICK SANCILIO	Director	STUART, FL
Albert Cavagnaro	Executive Officer	Riviera Beach, FL
Geoffrey Glass	Executive Officer	Riviera Beach, FL
Tony Lodovico	Executive Officer	Riviera Beach, FL
Leandra Mollanazar	Executive Officer	Riviera Beach, FL
Thorsteinn Thorsteinsson	Executive Officer	Riviera Beach, FL
Marc Wolff	Executive Officer	Riviera Beach, FL

More